El tratamiento radiante en el angiofibroma juvenil de nasofaringe: resultados en 6 pacientes
Alert, José; Caballero, Iraida; Reno, Jesús; García, Débora; Pérez, Lourdes.
Rev. cuba. med
; 43(1)ene.-feb. 2004. tab
Artículo en Español | LILACS | ID: lil-396608
Documentos relacionados
Extended Endonasal Endoscopic (EEE) Surgery with Almost No Use of Adjuvant Radiotherapy for Juvenile Nasopharyngeal Angiofibroma (JNA).
[The maxillary swing approach in surgycal treatment of the extensive juvenile nasopharyngeal angiofibroma].
Perioperative management of pediatric patients undergoing juvenile angiofibroma resection. A case series and educational review highlighting patient blood management.
Long-term monitoring and predictive factors of critical weight loss among patients with nasopharyngeal carcinoma in a curative treatment setting.
[The expression of clock gene CLOCK and its clinical significance in nasopharyngeal carcinoma].
Endoscopic, endoscopic-assisted and open approaches in the treatment of juvenile angiofibroma: what has been new in the past decade (and 1586 cases)?
Electron microscopy of juvenile nasopharyngeal angiofibroma: clinical and histopathological correlates.
Preoperative emobilisation of juvenile nasopharyngeal angiofibroma.
CNS infection with a history of recurrent epistaxis: Streptococcal meningitis as a first presentation of juvenile nasopharyngeal angiofibroma.
Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?